Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Martek

This article was originally published in The Tan Sheet

Executive Summary

International expansion boosts Q3 nutritional product sales to $4.9 mil., up 166% from last year's third quarter, firm says during Sept. 13 analysts call. Company's licensed products are now in 25 countries, five more than reported in second quarter. Clinical studies are underway to examine DHA's effects on women with bipolar disorder and on the cardiovascular system, company says. Total revenues for the quarter ended July 31 were up 127% to $5.6 mil.; net loss of $3.3 mil. was an improvement upon $3.8 mil. net loss during the year-ago quarter
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS093037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel